Advertisement

Hybrid Epicardial-Endocardial Approach to Atrial Fibrillation Ablation

  • Khola Tahir
  • Andy Kiser
  • Thomas Caranasos
  • J. Paul Mounsey
  • Anil Gehi
Arrhythmia (G Upadhyay, Section Editor)
  • 178 Downloads
Part of the following topical collections:
  1. Topical Collection on Arrhythmia

Abstract

Who should undergo hybrid AF ablation?

Patients with symptomatic persistent or long-standing persistent atrial fibrillation refractory to pharmacological or routine catheter ablation can be considered for hybrid epicardial-endocardial AF ablation. Although it seems clear that patient selection should be important when considering hybrid AF ablation for optimal results, unfortunately, available data on the outcomes of hybrid epicardial-endocardial ablation is limited. Hybrid ablation is rarely compared to stand-alone catheter ablation, the surgical approach (access site, lesion set, ablation tool) is inconsistent, and the patient population studied is often suitable for a catheter ablation approach (paroxysmal AF, minimal structural heart disease). We believe that the hybrid approach should be considered in patients who either have had unsuccessful catheter ablations or have significant structural heart disease evident by enlarged left atrial size or atrial fibrosis. These are the patients who warrant the added risk of a hybrid approach and who stand to benefit from a more extensive ablation including isolation of the posterior wall of the left atrium. Multi-center studies with a uniform hybrid ablation approach and comparison with a stand-alone catheter ablation approach are needed to help clarify the role of hybrid AF ablation.

Keywords

Hybrid AF ablation Epicardial-endocardial ablation Arrhythmia 

Notes

Compliance with Ethical Standards

Conflict of Interest

Khola Tahir and Thomas Caranasos each declare no potential conflicts of interest. Andy Kiser is a consultant for Atricure, Inc. J. Paul Mounsey is a consultant for Atricure, Inc., Boston Scientific, and Medtronic. Anil Gehi reports research funding from Bristol-Myers Squibb Foundation and speaker’s honoraria from Zoll Inc. and Abbott Inc.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Prasad SM, Maniar HS, Camillo HS, et al. The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone vs. concomitant procedures. J Thorac Cardiovasc Surg. 2003;126(6):1822–8.  https://doi.org/10.1016/S0022-5223(03)01287-X.CrossRefPubMedGoogle Scholar
  2. 2.
    Robertson JO, Saint LL, Leidenfrost JE, Damiano RJ Jr. Illustrated techniques for performing Cox-Maze IV procedure through a right mini-thoracotomy. Ann Cardiothorac Surg. 2014;3(1):105–16.  https://doi.org/10.3978/j.issn.2225-319X.2013.12.11.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg. 1991;101(4):584–92.PubMedGoogle Scholar
  4. 4.
    Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–66.  https://doi.org/10.1056/NEJM199809033391003.CrossRefPubMedGoogle Scholar
  5. 5.
    Ganesan AN, Shipp NJ, Brooks AJ, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e004549.  https://doi.org/10.1161/JAHA.112.004549.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    McCready J, Smedley T, Lambiase PD, et al. Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation. Eur Secur. 2011;13:355–61.Google Scholar
  7. 7.
    Mahapatra S, LaPar DJ, Kamath S, Payne J, Bilchick KC, Mangrum JM, et al. Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up. Ann Thorac Surg. 2011;91(6):1890–8.  https://doi.org/10.1016/j.athoracsur.2011.02.045.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bulava A, Mokracek A, Hanis J, Kurfirst V, Eisenberger M, Pesl L. Sequential hybrid procedure for persistent atrial fibrillation. J Am Heart Assoc. 2015;4(3):e001754.  https://doi.org/10.1161/JAHA.114.001754.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Krul SP, Driessen AH, van Boven WJ, et al. Thoracoscopic video-assisted pulmonary vein antrum isolation, ganglionated plexus ablation, and periprocedural confirmation of ablation lesions: first results of a hybrid surgical-electrophysiological approach for atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(3):262–70.  https://doi.org/10.1161/CIRCEP.111.961862.CrossRefPubMedGoogle Scholar
  10. 10.
    Pison L, La Meir M, van Opstal J, Blaauw Y, Maessen J, Crijns HJ. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2012;60(1):54–61.  https://doi.org/10.1016/j.jacc.2011.12.055.CrossRefPubMedGoogle Scholar
  11. 11.
    La Meir M, Gelsomino S, Luca F, et al. Minimally invasive surgical treatment of lone atrial fibrillation: early results of hybrid versus standard minimally invasive approach employing radiofrequency sources. Int J Cardiol. 2013;167(4):1469–75.  https://doi.org/10.1016/j.ijcard.2012.04.044.CrossRefPubMedGoogle Scholar
  12. 12.
    Pison L, Gelsomino S, Luca F, et al. Effectiveness and safety of simultaneous hybrid thoracoscopic and endocardial catheter ablation of lone atrial fibrillation. Ann Cardiothorac Surg. 2014;3(1):38–44.  https://doi.org/10.3978/j.issn.2225-319X.2013.12.10.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Kurfirst V, Mokracek A, Bulava A, et al. Two-staged hybrid treatment of persistent atrial fibrillation: short-term single-centre results. Interact Cardiovasc Thorac Surg. 2014;18(4):451–6.  https://doi.org/10.1093/icvts/ivt538.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    La Meir M, Gelsomino S, Luca F, Lorusso R, Gensini GF, Pison L, et al. Minimally invasive thoracoscopic hybrid treatment of lone atrial fibrillation: early results of monopolar versus bipolar radiofrequency. Interact Cardiovasc Thorac Surg. 2012;14(4):445–50.  https://doi.org/10.1093/icvts/ivr142.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Munretto C, Bisleri G, Bontempi L, et al. Successful treatment of long persistent atrial fibrillation by means of a hybrid thoracoscopic-transcatheter approach. Innovations. 2012;7(4):254–8.Google Scholar
  16. 16.
    Bisleri G, Rosati F, Bontempi L, Curnis A, Muneretto C. Hybrid approach for the treatment of long-standing persistent atrial fibrillation: electrophysiological findings and clinical results. Eur J Cardiothorac Surg. 2013;44(5):919–23.  https://doi.org/10.1093/ejcts/ezt115.CrossRefPubMedGoogle Scholar
  17. 17.
    • Gehi AK, Mounsey JP, Pursell I, et al. Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm. 2013;10(1):22–8. This is one the largest series of hybrid AF ablation using the pericardioscopic technique which allows for direct access to the pericardium with shorter recovery times compared to the other surgical approaches. It included patients with serious comorbidities and found a reasonable success rate in this complex patient population.  https://doi.org/10.1016/j.hrthm.2012.08.044.CrossRefPubMedGoogle Scholar
  18. 18.
    Gersak B, Pernat A, Robic B, et al. Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23(10):1059–66.  https://doi.org/10.1111/j.1540-8167.2012.02355.x.CrossRefPubMedGoogle Scholar
  19. 19.
    • Gersak B, Zembala MO, Muller D, et al. European experience of the convergent atrial fibrillation procedure: multicenter outcomes in consecutive patients. J Thorac Cardiovasc Surg. 2014;147(4):1411–6. This is one of the only multi-center studies of hybrid AF ablation and it only included patients with either LSP or persistent AF. It showed that the convergent hybrid procedure is successful at achieving sinus rhythm in this patient population and the need for repeat procedures is low.  https://doi.org/10.1016/j.jtcvs.2013.06.057.CrossRefPubMedGoogle Scholar
  20. 20.
    Civello KC, Smith CA, Boedefeld W, et al. Combined endocardial and epicardial ablation for symptomatic atrial fibrillation: single center experience. J Innov Card Rhythm Mgmt. 2013;4(9):1367.Google Scholar
  21. 21.
    Zembala M, Filipiak K, Kowalski O, Boidol J, Sokal A, Lenarczyk R, et al. Minimally invasive hybrid ablation procedure for the treatment of persistent atrial fibrillation: one year results. Kardiol Pol. 2012;70(8):819–28.PubMedGoogle Scholar
  22. 22.
    • Kress DC, Erickson L, Choudhuri I, et al. Comparative effectiveness of hybrid ablation versus endocardial catheter ablation alone in patients with persistent atrial fibrillation. JACC: Clinical Electrophysiology. 2017;3(4):341–9. This is the most recent study looking at hybrid AF ablation vs. endocardial catheter ablation. It showed that the hybrid group had higher freedom from AF and less need for repeat ablation.Google Scholar
  23. 23.
    Gehi AG, Caranasos T, Mounsey JP et al. Initial experience with trans-xiphoid hybrid endocardial and epicardial ablation for atrial fibrillation. HRS Abstract. Heart Rhythm. 2017;14(5)Supp:S181.Google Scholar
  24. 24.
    Richardson TD, Shoemaker BM, Whalen SP, et al. Staged versus simultaneous thoracoscopic hybrid ablation for persistent atrial fibrillation does not affect time to recurrence of atrial arrhythmia. J Cardiovasc Electrophysiol. 2016;27(4):428–43.  https://doi.org/10.1111/jce.12906.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Khola Tahir
    • 1
  • Andy Kiser
    • 2
  • Thomas Caranasos
    • 3
  • J. Paul Mounsey
    • 4
  • Anil Gehi
    • 1
  1. 1.Division of Cardiology, Department of MedicineUniversity of North Carolina at Chapel HillChapel HillUSA
  2. 2.Division of Cardiac SurgeryEast Carolina Heart InstituteGreenvilleUSA
  3. 3.Division of Cardiothoracic Surgery, Department of SurgeryUniversity of North CarolinaChapel HillUSA
  4. 4.Division of CardiologyEast Carolina Heart InstituteGreenvilleUSA

Personalised recommendations